SCHEMBL6416129

SCHEMBL6416129

O=C(Cc1ccc(Cl)c(Cl)c1)NC(CCN1CCC2(CC1)CCN(Cc1ccc(Br)cc1)C2=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
CCR5 P51681 4/20 0.42
SIGMAR1 Q99720 4/20 0.41
LIPG Q9Y5X9 1/20 0.41
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
S1PR3 Q99500 1/20 0.37
UTS2R Q9UKP6 2/20 0.37
OPRM1 P35372 2/20 0.37
OPRD1 P41143 2/20 0.37
OPRK1 P41145 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6411342 0.99 HTT (0.43) HTTCCR5SIGMAR1LIPGSLC6A2
SCHEMBL6409316 0.92 SIGMAR1 (0.44) HTTCCR5SIGMAR1UTS2RALDH1A1
SCHEMBL6415648 0.91 CCR5 (0.41) CCR5SIGMAR1UTS2RALDH1A1
Hydrochloric Acid SCHEMBL6413451 0.91 SIGMAR1 (0.43) HTTCCR5SIGMAR1UTS2RALDH1A1
Hydrochloric Acid SCHEMBL6414857 0.91 CCR5 (0.41) CCR5SIGMAR1UTS2RALDH1A1
SCHEMBL6409255 0.91 CCR5 (0.49) HTTCCR5SIGMAR1LIPGUTS2R
SCHEMBL6417591 0.90 SIGMAR1 (0.39) CCR5SIGMAR1UTS2RALDH1A1
Hydrochloric Acid SCHEMBL6415252 0.90 CCR5 (0.49) HTTCCR5SIGMAR1LIPGUTS2R
Hydrochloric Acid SCHEMBL6411335 0.89 SIGMAR1 (0.39) CCR5SIGMAR1UTS2RALDH1A1
SCHEMBL6416207 0.89 CCR5 (0.46) HTTCCR5SIGMAR1LIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 HTT 4137/4885CCR5 4/4885SIGMAR1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.